BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15158448)

  • 1. Sall1, a causative gene for Townes-Brocks syndrome, enhances the canonical Wnt signaling by localizing to heterochromatin.
    Sato A; Kishida S; Tanaka T; Kikuchi A; Kodama T; Asashima M; Nishinakamura R
    Biochem Biophys Res Commun; 2004 Jun; 319(1):103-13. PubMed ID: 15158448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse homolog of SALL1, a causative gene for Townes-Brocks syndrome, binds to A/T-rich sequences in pericentric heterochromatin via its C-terminal zinc finger domains.
    Yamashita K; Sato A; Asashima M; Wang PC; Nishinakamura R
    Genes Cells; 2007 Feb; 12(2):171-82. PubMed ID: 17295837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
    Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM
    Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome.
    Kohlhase J; Wischermann A; Reichenbach H; Froster U; Engel W
    Nat Genet; 1998 Jan; 18(1):81-3. PubMed ID: 9425907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a truncated Sall1 transcriptional repressor is responsible for Townes-Brocks syndrome birth defects.
    Kiefer SM; Ohlemiller KK; Yang J; McDill BW; Kohlhase J; Rauchman M
    Hum Mol Genet; 2003 Sep; 12(17):2221-7. PubMed ID: 12915476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma.
    Shibata T; Chuma M; Kokubu A; Sakamoto M; Hirohashi S
    Hepatology; 2003 Jul; 38(1):178-86. PubMed ID: 12830000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the heterochromatin localization and repression domains of SALL1.
    Netzer C; Bohlander SK; Hinzke M; Chen Y; Kohlhase J
    Biochim Biophys Acta; 2006 Mar; 1762(3):386-91. PubMed ID: 16443351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine Nr4a1 and Herpud1 are up-regulated by Wnt-1, but the homologous human genes are independent from beta-catenin activation.
    Chtarbova S; Nimmrich I; Erdmann S; Herter P; Renner M; Kitajewski J; Müller O
    Biochem J; 2002 Nov; 367(Pt 3):723-8. PubMed ID: 12153396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SALL1 mutation analysis in Townes-Brocks syndrome: twelve novel mutations and expansion of the phenotype.
    Botzenhart EM; Green A; Ilyina H; König R; Lowry RB; Lo IF; Shohat M; Burke L; McGaughran J; Chafai R; Pierquin G; Michaelis RC; Whiteford ML; Simola KO; Rösler B; Kohlhase J
    Hum Mutat; 2005 Sep; 26(3):282. PubMed ID: 16088922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
    Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
    Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-catenin is critical for dendritic morphogenesis.
    Yu X; Malenka RC
    Nat Neurosci; 2003 Nov; 6(11):1169-77. PubMed ID: 14528308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SALL1 mutations in Townes-Brocks syndrome and related disorders.
    Kohlhase J
    Hum Mutat; 2000 Dec; 16(6):460-6. PubMed ID: 11102974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies.
    Valenta T; Lukas J; Doubravska L; Fafilek B; Korinek V
    EMBO J; 2006 Jun; 25(11):2326-37. PubMed ID: 16724116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SALL1, the gene mutated in Townes-Brocks syndrome, encodes a transcriptional repressor which interacts with TRF1/PIN2 and localizes to pericentromeric heterochromatin.
    Netzer C; Rieger L; Brero A; Zhang CD; Hinzke M; Kohlhase J; Bohlander SK
    Hum Mol Genet; 2001 Dec; 10(26):3017-24. PubMed ID: 11751684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signaling through canonical and non-canonical pathways: recent progress.
    Widelitz R
    Growth Factors; 2005 Jun; 23(2):111-6. PubMed ID: 16019432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of heterozygous SALL1 deletions by quantitative real time PCR proves the contribution of a SALL1 dosage effect in the pathogenesis of Townes-Brocks syndrome.
    Borozdin W; Steinmann K; Albrecht B; Bottani A; Devriendt K; Leipoldt M; Kohlhase J
    Hum Mutat; 2006 Feb; 27(2):211-2. PubMed ID: 16429401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell biology. Wnt signaling glows with RNAi.
    Fearon ER; Cadigan KM
    Science; 2005 May; 308(5723):801-3. PubMed ID: 15879199
    [No Abstract]   [Full Text] [Related]  

  • 20. The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development.
    Sakaki-Yumoto M; Kobayashi C; Sato A; Fujimura S; Matsumoto Y; Takasato M; Kodama T; Aburatani H; Asashima M; Yoshida N; Nishinakamura R
    Development; 2006 Aug; 133(15):3005-13. PubMed ID: 16790473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.